Performa HargaHarga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)0.82
Harga Terendah (52 Minggu)0.47
Latar Belakang Perusahaan
Perusahaan biofarmasi yang berfokus pada pengembangan dan komersialisasi terapi inovatif untuk penyakit infeksi dan perawatan kritis.
Summary
Valuation Information
Current PE Ratio (TTM)-0.31
Forward PE Ratio0.31
Current Price to Book Value0.24
Current Price to Sales2.15
EV to Revenue2.66
EV to EBITDA-2.74
PEG Ratio-
Per Share
Current EPS (Annualized)-2.14
Diluted EPS (TTM)-2.14
Revenue Per Share0.31
Current Book Value Per Share2.75
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date2017-06-09
Income Statement
EBITDA-53851096
Profit Margin0
Operating Margin-18.28
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
